These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12664059)

  • 1. Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.
    Bevan S; Edwards SM; Ardern Jones A; Dowe A; Southgate C; Dearnaley D; Easton DF; Houlston RS; Eeles RA;
    Prostate Cancer Prostatic Dis; 2003; 6(1):12-4. PubMed ID: 12664059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No germline FH mutations in familial breast cancer patients.
    Kiuru M; Lehtonen R; Eerola H; Aittomäki K; Blomqvist C; Nevanlinna H; Aaltonen LA; Launonen V
    Eur J Hum Genet; 2005 Apr; 13(4):506-9. PubMed ID: 15523491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies.
    Gross KL; Panhuysen CI; Kleinman MS; Goldhammer H; Jones ES; Nassery N; Stewart EA; Morton CC
    Genes Chromosomes Cancer; 2004 Nov; 41(3):183-90. PubMed ID: 15334541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
    Tomlinson IP; Alam NA; Rowan AJ; Barclay E; Jaeger EE; Kelsell D; Leigh I; Gorman P; Lamlum H; Rahman S; Roylance RR; Olpin S; Bevan S; Barker K; Hearle N; Houlston RS; Kiuru M; Lehtonen R; Karhu A; Vilkki S; Laiho P; Eklund C; Vierimaa O; Aittomäki K; Hietala M; Sistonen P; Paetau A; Salovaara R; Herva R; Launonen V; Aaltonen LA;
    Nat Genet; 2002 Apr; 30(4):406-10. PubMed ID: 11865300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
    Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
    Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
    Kiuru M; Lehtonen R; Arola J; Salovaara R; Järvinen H; Aittomäki K; Sjöberg J; Visakorpi T; Knuutila S; Isola J; Delahunt B; Herva R; Launonen V; Karhu A; Aaltonen LA
    Cancer Res; 2002 Aug; 62(16):4554-7. PubMed ID: 12183404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
    Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
    Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
    Alam NA; Olpin S; Leigh IM
    Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene.
    Chuang GS; Martinez-Mir A; Engler DE; Gmyrek RF; Zlotogorski A; Christiano AM
    Clin Exp Dermatol; 2006 Jan; 31(1):118-21. PubMed ID: 16309500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata.
    Chuang GS; Martinez-Mir A; Geyer A; Engler DE; Glaser B; Cserhalmi-Friedman PB; Gordon D; Horev L; Lukash B; Herman E; Cid MP; Brenner S; Landau M; Sprecher E; Garcia Muret MP; Christiano AM; Zlotogorski A
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):410-6. PubMed ID: 15761418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline ATBF1 mutations and prostate cancer risk.
    Xu J; Sauvageot J; Ewing CM; Sun J; Liu W; Isaacs SD; Wiley KE; Diaz L; Zheng SL; Walsh PC; Isaacs WB
    Prostate; 2006 Jul; 66(10):1082-5. PubMed ID: 16637072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
    Alam NA; Olpin S; Rowan A; Kelsell D; Leigh IM; Tomlinson IP; Weaver T
    J Mol Diagn; 2005 Oct; 7(4):437-43. PubMed ID: 16237213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
    Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
    Chan I; Wong T; Martinez-Mir A; Christiano AM; McGrath JA
    Clin Exp Dermatol; 2005 Jan; 30(1):75-8. PubMed ID: 15663510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.
    Zuhlke KA; Madeoy JJ; Beebe-Dimmer J; White KA; Griffin A; Lange EM; Gruber SB; Ostrander EA; Cooney KA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5975-80. PubMed ID: 15447980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer.
    Hu N; Wang C; Han XY; He LJ; Tang ZZ; Giffen C; Emmert-Buck MR; Goldstein AM; Taylor PR
    Oncogene; 2004 Jan; 23(3):852-8. PubMed ID: 14647438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
    Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
    Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.
    Lehtonen R; Kiuru M; Vanharanta S; Sjöberg J; Aaltonen LM; Aittomäki K; Arola J; Butzow R; Eng C; Husgafvel-Pursiainen K; Isola J; Järvinen H; Koivisto P; Mecklin JP; Peltomäki P; Salovaara R; Wasenius VM; Karhu A; Launonen V; Nupponen NN; Aaltonen LA
    Am J Pathol; 2004 Jan; 164(1):17-22. PubMed ID: 14695314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC).
    Heinritz W; Paasch U; Sticherling M; Wittekind C; Simon JC; Froster UG; Renner R
    Ann Hum Genet; 2008 Jan; 72(Pt 1):35-40. PubMed ID: 17908262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
    White KA; Lange EM; Ray AM; Wojno KJ; Cooney KA
    Prostate Cancer Prostatic Dis; 2006; 9(3):298-302. PubMed ID: 16733518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.